Objective: To examine the effect of euglycemic blood glucose control with normal insulin therapy on the incidence of critical illness polyneuropathy and duration of mechanical ventilation compared to that of conventional insulin therapy in a medical ICU. Background: Despite the criticism over increased risk of hypoglycemia, the prevention of hyperglycemia through intensive insulin therapy has recently been confi rmed to reduce the critical illness polyneuropathy (CIP). Methods: In a single blind randomized clinical trial, forty adult patients admitted to the medical ICU were randomized to either euglycemic control (80-140 mg/dL) (Group N) or conventional approach (180-200 mg/dL, Group C). Duration of mechanical ventilation and the presence of CIP were investigated. Results: The mean blood glucose levels were 131.76 ± 40.15 mg/dL in group N and 169.87 ± 50.66 mg/dL in group C (p < 0.001). Patients in group N were on mechanical ventilation for signifi cantly less time than those in group C (p = 0.04). The diagnosis of CIP was signifi cantly more frequent in group C than in group N (p = 0.01). Conclusions: Glucose control at levels 80-140 mg/dL with normal insulin administration is likely to be associated with both reduced incidence of CIP and duration of ventilator dependency in medical ICU (Tab. 3, Ref. 24). Full Text in PDF www.elis.sk.
Critical illness polyneuropathy (CIP) principally affects the motor and sensory axons in critically ill patients (1, 2) . This disorder not only causes severe limb weakness and subsequent prolonged rehabilitation but also detrimentally protracts weaning from mechanical ventilation (1, 3) . The latter is attributed to the involvement of the phrenic nerves and the diaphragm, intercostal and other accessory respiratory muscles (4) . Numerous related risk factors have been studied among which sepsis, systemic infl ammatory response syndrome, and multiple organ failure have been recognized as fundamental parameters (5) . Also, the role of corticosteroids and neuromuscular blocking agents in the development of CIP is still a matter of controversy (1) . Recognition of these risk factors is of the utmost importance since only preventive and supportive measures have hitherto been recommended to hinder the progression of CIP (1) . Nevertheless, among these probable interventions, only prevention of hyperglycemia through intensive insulin therapy (IIT) has recently been confi rmed to benefi t patients admitted to the intensive care unit (ICU) (1, 6) . In the Leuven trials, Van den Berghe et al. found that tight blood glucose control with insulin in medical/surgical ICU reduced CIP and the need for prolonged mechanical ventilation (7) (8) (9) . Nonetheless, blood glucose at the target level of 80-110 mg/dL has been criticized because it increases the risk of hypoglycemia and subsequent mortality (10) . Therefore, our aim was to examine the effect of euglycemia (aiming at a blood glucose level of 80-140 mg/dL) through normal insulin therapy (NIT) on the incidence of CIP and duration of mechanical ventilation compared to that of conventional insulin therapy in a medical ICU population.
Methods
In a single blind randomized clinical trial during eighteen months from July 2005 to January 2007, forty adult patients (20-80 years) admitted to the university-affi liated medical ICU with Acute Physiology and Chronic Health Evaluation (APACHE II) with score >10 were eligible for inclusion. The study was approved by the local ethics committee and written informed consent was obtained from the closest family member. Exclusion criteria were (1) history of diabetes mellitus (blood glucose level ≥ 126 mg/dL) with or without medical therapy, (2) history of cirrhosis or chronic liver disease, (3) history of malignancy, (4) body mass index (BMI) < 8 or > 35, (5) a 48-hour delay in admission to ICU, and (6) diagnosis of polyneuropathy on second-day electrophysiological study (see Electrophysiological study). Of forty patients, 20 cases were randomized to euglycemic control with normal insulin therapy (Group N) and the remaining to the conventional approach (Group C). Age, gender, height, weight, BMI, APACHE II score, blood glucose level, values of electrodiagnostic study in upper and lower limbs, duration of mechanical ventilation, and presence of CIP were recorded. The blood glucose level was measured on admission and daily at 6 A.M. Laboratory personnel were unaware of the treatment assignments. The feeding regimen and medical interventions were similar in both groups.
Blood glucose measurements
With the aim of maintaining blood glucose level in the range of 80-140 mg/dL in the normal insulin therapy group (Group N), insulin infusion was started when a glucose level over 140 mg/dL was detected. Once the blood glucose level fell below 100 mg/dL, blood glucose level measurements were performed every hour. At a glucose level of 60 mg/dL, insulin infusion was stopped. With diagnosis of hypoglycemia at blood glucose levels below 45 mg/ dL, intravenous glucose (50 %) was given. Infusion of insulin was not started until the blood glucose rose above 140 mg/dL. The conventional insulin therapy (Group C) approach required insulin only when the blood glucose rose above 250 mg/dL. The insulin dose was regulated on the basis of blood glucose levels measured at one-to-four hour intervals in capillary blood. Conventional insulin therapy was aimed at blood glucose levels between 180 and 200 mg/dL, i.e. infusion of insulin was stopped when blood glucose fell below 180 mg/dL. In both groups, the infusion of insulin was discontinued when enteral feeding was halted.
Electrophysiological study
All the recruited patients were assessed electrophysiologically on days 2, 10 and 18 after admission. Patients with pre-existing neuromuscular disorders due to diabetes mellitus, chronic renal failure, cirrhosis and malignancies were excluded. In addition, patients whose second-day electrophysiological study was suggestive of polyneuropathy were not included. Electrodiagnostic surveys were performed by an independent neurologist (M.Y.M) who was unaware of treatment allocation. Sensory and motor nerve conduction velocities (NCV) and amplitude of action potentials were recorded by an EMG-NC (Toenniss Neuroscreen plus, Erich Jaeger GmbH, Hoechberg, Germany). Compound muscle action potential (CMAP) was assessed by stimulation of the median, ulnar, peroneal and tibial nerves and on abductor pollicis brevis, abductor digiti minimi, extensor digitorum brevis, and abductor hallucis muscles. Sensory nerve action potential (SNAP) values on the sural nerve and sensory parts of the median and ulnar nerves were also recorded. The diagnosis of critical illness polyneuropathy (CIP) was based on a reduction of >10 % in the values of CMAP and SNAP and confi rmed by physical examination of the patient.
Weaning strategies
Mechanically ventilated patients were evaluated daily for the probability of weaning based on improvement in indicators for mechanical ventilation, cardiovascular status, arterial blood gas parameters, ventilator settings and neurological status. If these criteria were met, a weaning-trial was performed using spontaneous breathing trials of at least 30 and up to 120 minutes. If the spontaneous breathing trial was successful, based on subjective tolerance, respiratory and hemodynamic parameters, the patients were extubated.
Statistics
Data are presented as mean ± standard deviation (SD). Statistical analysis was performed using SPSS for Windows version 13.0 (Chicago, IL) using Chi-square test, Fisher's exact test, MannWhitney U test, and Independent-Samples t test wherever appropriate. A p value < 0.05 was considered statistically signifi cant.
Results
A total of 40 of the 313 patients admitted to the medical ICU were evaluated; 20 patients in group N and 20 cases in group C. Demographic baseline data and outcome characteristics of these patients are shown in Table 1 . There were no differences in gender, age, BMI and APACHE II score (Tab. 1) (p > 0.05). The mean APACHE II score of all patients in both groups studied was 16.08 ± 3.47 (range: 11-24). According to the above defi nition, hypoglycemia was detected in fi ve patients on blood glucose level measurements with a glucometer (p > 0.05). None of these instances was accompanied by adverse events including cardiac arrest, seizures, and hypoglycemia-induced coma. The mean blood glucose levels (6 A.M.) were 131.76 ± 40.15 mg/dL in group N and 169.87 ± 50.66 mg/dL in group C (p < 0.001, Mann-Whitney U Group N (n = 20)
Group C (n = 20) p value Gender (male:female) 
Tab. 1. Demographic and outcome characteristics of study patients.
test) (Tab. 1). Patients in group N were on mechanical ventilator for signifi cantly less time than those in group C (9.72 ± 3.84 vs.
14.05 ± 8.14 days, p = 0.04, Mann-Whitney U test).
An electrophysiologically based diagnosis of CIP was significantly more frequent in group C (9/20 (45 %)) than in group N (2/20 (10 %)) (p = 0.01, Fisher's exact test). Features of limb nerve conduction on days 10 and 18 are listed in Tables 2 and 3 . The electrodiagnostic survey on day 18 showed that the mean sensory NCV of upper limbs in group C (44.89 ± 4.53 ms) was signifi cantly lower than that in group N (46.98 ± 8.14 ms) (p = 0.02) (Tab. 2). Furthermore, after one week, patients in group C showed greater reduction in motor NCV (upper limbs) and sensory NCV (lower limbs) than patients in group N (p = 0.007) (Tabs 2 and 3). In the lower limbs, electrophysiological values of the sensory nerves (amplitude and sensory NCV at day 18) were signifi cantly higher in group N (p < 0.05) (Tab. 3).
Discussion
The present study showed that in comparison to the conventional control of blood glucose, NIT may reduce the incidence of CIP and duration of ventilator dependency in the medical ICU. The results of this study complement those of previous publications. In a study on patients in surgical ICU, Van den Berghe et al. found that strict control of blood glucose levels by insulin (aimed at maintaining glycemia of 80-110 mg/dL) reduced CIP and the need for prolonged mechanical ventilation (7, 8) . Later in Leuven, Van den Berghe and colleagues studied the same insulin titration protocol in medical ICU. They obtained fi ndings similar to those of the previous surgical ICU investigation, revealing a reduced incidence of CIP and earlier weaning from mechanical ventilation in patients on IIT (2, 9). These conclusions have recently been reconfi rmed in an electrophysiologically based retrospective study in the medical/surgical ICU (5) . In the present study, patients with history of diabetes mellitus were excluded in order to investigate the effects of normal glucose control on stress-induced hyperglycemia (SIH) rather than on diabetic hyperglycemia. We believe that this is an important characteristic of our study. Although increased risk of hospital mortality and longer duration of hospitalization have been indicated in SIH vs. diabetic hyperglycemia, most of the recent randomized studies have included both SIH and diabetic hyperglycemia in the same analysis (10) .
Diagnosis of CIP is based on technical investigations including measurements of serum creatine kinase, electrophysiological studies, and muscle biopsy (10). Among these, electrophysiological studies (EMG/NCV) are applied not only to confi rm the diagnosis but also to rule out other neuromuscular causes of weakness (1, 10) . Prior to the onset of clinical symptoms and electromyographical changes there is a reduction in amplitude of CMAP and/or SNAP with preserved conduction velocity (1, 11) . However, some believe that a decline in SNAP amplitude occurs later than in CMAP (3, 10) . Although in most previous studies examining the role of IIT in CIP, CIP has been diagnosed according to the above criteria (2, 7-9), they have almost all neglected to report their electrophysiological data. Nonetheless, Hermans and coworkers reported that SNAP values in the upper limbs were signifi cantly increased in their IIT group (5). They attributed the absence of electrophysiological alterations in the lower limbs to the vulnerability of the sural nerve to tissue edema (5) .
The core mechanism underlying the benefi cial effects of IIT in reducing mortality and morbidity might be partially elucidated by a hypothesis of impaired microvascular circulation (11, 13) . According to this hypothesis, hyperglycemia in critically ill patients may lead to impairment of microcirculation to peripheral nerves, augmenting the occurrence of CIP (11, 13) . Later studies of IIT concerning asymmetric dimethylarginine (nitric oxide synthase inhibitor) (14) , intracellular adhesion molecules and E-selectin (15) seem consistent with the hypothesis. Moreover, the plausible anti-infl ammatory effects of insulin (16) and its protective effects on neuronal mitochondria (8, 17) and serum lipid profi le (18) have been linked to reduced incidence of CIP in patients on IIT. Nevertheless, tight glucose control (aimed at maintaining glycemia of 80-110 mg/dL) has often been accompanied by increased risk of hypoglycemia (7, 9, 19) . For that reason, two recent related trials have been stopped (20, 21 reveal signifi cant differences between IIT and conventional therapy groups regarding morbidity and mortality (10) . Likewise, the fi ndings of the Normoglycemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE-SUGAR) study revealed greater mortality and more severe hypoglycemia in IIT than in conventional therapy groups (22, 23). On the basis of these results, the American Diabetes Association and the American Association of Clinical Endocrinologists have recommended that until more data are available, it is reasonable to treat critically ill patients less rigorously rather than attempt to achieve blood glucose levels in the range of 80 to 108 mg/dL (24) . At the target blood glucose level of 80-140 mg/dL, patients on NIT in the present study developed fewer CIPs and remained for shorter times on mechanical ventilation than those on conventional therapy. Moreover, a similar incidence of hypoglycemia with no subsequent adverse complications between the two groups in our study further highlights the benefi ts of NIT compared to tight glucose control through IIT.
In conclusion, control of glucose levels at 80-140 mg/dL with normal insulin administration is likely to be associated with both reduced incidence of CIP and duration of ventilator dependency in medical ICU. Further investigations are needed to assess the benefi ts of blood glucose control at different targets, in particular those less aggressively achieved by insulin administration.
